CLSI C52-A2

Toxicology and Drug Testing in the Clinical Laboratory; Approved Guideline, Second Edition, C52A2E

Clinical and Laboratory Standards Institute, 04/01/2007

Publisher: CLSI

File Format: PDF

$143.00$287.20

Description

Published:01/04/2007

Pages:68

This guideline addresses drug testing in the clinical laboratory, both for clinical and forensic purposes, and pertains to both drugs of abuse and other drugs normally encountered and analyzed by hospital laboratories.

The guideline discusses the preanalytical, analytical, and postanalytical considerations for specimen collection, methods of analysis, quality assurance, and the reporting and interpretation of results.

More CLSI standard pdf

CLSI I/LA25-A2 (R2018)

Maternal Serum Screening; Approved Standard, Second Edition, I/LA25A2

$90.00 $180.00

CLSI M24-A2

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24A2E

$90.00 $180.00

CLSI AUTO12-A (R2018)

Specimen Labels: Content and Location, Fonts, and Label Orientation; Approved Standard, AUTO12AE

$90.00 $180.00

CLSI H59-A (R2018)

Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Proposed Guideline, H59AE

$90.00 $180.00